Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-065603

President sold 45,000 shares at an average $60.49 ($2,722,179)

  • President acquired 45,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
RUBINSTEIN JULIE President 2020-12-28 Option exercise +15,000 $6.32 $94,800 15,000 D
RUBINSTEIN JULIE President 2020-12-28 Sale −8,807 $60.89 $536,258 6,193 D
RUBINSTEIN JULIE President 2020-12-28 Sale −3,735 $62.04 $231,719 2,458 D
RUBINSTEIN JULIE President 2020-12-28 Sale −2,258 $63.33 $142,999 200 D
RUBINSTEIN JULIE President 2020-12-28 Sale −200 $63.95 $12,790 0 D
RUBINSTEIN JULIE President 2020-12-29 Option exercise +15,000 $6.32 $94,800 15,000 D
RUBINSTEIN JULIE President 2020-12-29 Sale −6,225 $59.48 $370,263 8,775 D
RUBINSTEIN JULIE President 2020-12-29 Sale −6,922 $60.72 $420,304 1,853 D
RUBINSTEIN JULIE President 2020-12-29 Sale −1,853 $61.32 $113,626 0 D
RUBINSTEIN JULIE President 2020-12-30 Option exercise +15,000 $6.32 $94,800 15,000 D
RUBINSTEIN JULIE President 2020-12-30 Sale −13,300 $59.55 $792,015 1,700 D
RUBINSTEIN JULIE President 2020-12-30 Sale −1,700 $60.12 $102,204 0 D
Derivatives
RUBINSTEIN JULIE President 2020-12-28 Option exercise · Stock Option (Right to Buy) −15,000 425,000 D
RUBINSTEIN JULIE President 2020-12-29 Option exercise · Stock Option (Right to Buy) −15,000 410,000 D
RUBINSTEIN JULIE President 2020-12-30 Option exercise · Stock Option (Right to Buy) −15,000 395,000 D
Open-market sales · 45,000 sh · avg $60.49 · $2,722,179
Loading xslF345X03/doc4.xml…